MacuLogix Raises $3.6M Series A

MacuLogix Inc., startup focused on early detection and tracking of age-related macular degeneration, has raised a $3.6 million Series A round. Investors include Berwind Private Equity, Roche Venture Fund, Life Sciences Greenhouse of Central Pennsylvania, and Ben Franklin Technology Partners of Central and Northern Pennsylvania. The company is based in Hummelstown, Penn.

11 March 2013•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail